本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Actinium Pharmaceuticals, Inc.

1.21
+0.02001.68%
成交量:4.42萬
成交額:5.32萬
市值:3,796.37萬
市盈率:3.40
高:1.22
開:1.20
低:1.19
收:1.19
52周最高:1.74
52周最低:0.7351
股本:3,137.50萬
流通股本:3,088.79萬
量比:0.40
換手率:0.14%
股息:- -
股息率:- -
每股收益(TTM):0.3559
每股收益(LYR):-1.0900
淨資產收益率:45.86%
總資產收益率:11.58%
市淨率:1.25
市盈率(LYR):-1.11

資料載入中...

2022/05/13

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/04/13

重要事件披露

8-K - Current report
2022/03/25

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/09/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/09/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/09/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/09/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/09/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/07/30

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/14

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/03/31

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/05

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/11/20

重要事件披露

8-K - Current report
2020/10/28

重要事件披露

8-K - Current report
2020/10/23

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/14

SEC問詢函

CORRESP [Cover] - Correspondence
2020/08/14

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/14

重要事件披露

8-K - Current report